Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Kidney International
|
March 20, 2018
Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice
Angelique L W M M Rops, Erik Jansen, Alie van der Schaaf, et al.
Clinical Kidney Journal
|
September 3, 2025
Identification of early predictors of clinical remission in primary membranous nephropathy: a <i>post hoc</i> analysis of the STARMEN trial
Jorge E Rojas-Rivera, Fernando Caravaca-Fontán, Anne-Els van de Logt, et al.
JCI Insight
|
January 16, 2024
C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy
Qi Zhang, Sofia Bin, Kelly Budge, et al.
Pediatric Nephrology (Berlin, Germany)
|
October 21, 2022
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
Agnes Trautmann, Olivia Boyer, Elisabeth Hodson, et al.
Clinical Chemistry and Laboratory Medicine
|
July 4, 2023
Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease
Marith van Schrojenstein Lantman, Anne-Els van de Logt, Elma Prudon-Rosmulder, et al.
Kidney International
|
September 5, 2020
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients
Lena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
Orphanet Journal of Rare Diseases
|
June 3, 2021
The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results
Giulia Bassanese, Tanja Wlodkowski, Aude Servais, et al.
Kidney International
|
November 9, 2020
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernández-Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, et al.
Kidney International
|
December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
Fadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Autoimmunity Reviews
|
September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Kidney International
|
March 20, 2018
Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice
Angelique L W M M Rops, Erik Jansen, Alie van der Schaaf, et al.
Clinical Kidney Journal
|
September 3, 2025
Identification of early predictors of clinical remission in primary membranous nephropathy: a <i>post hoc</i> analysis of the STARMEN trial
Jorge E Rojas-Rivera, Fernando Caravaca-Fontán, Anne-Els van de Logt, et al.
JCI Insight
|
January 16, 2024
C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy
Qi Zhang, Sofia Bin, Kelly Budge, et al.
Pediatric Nephrology (Berlin, Germany)
|
October 21, 2022
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
Agnes Trautmann, Olivia Boyer, Elisabeth Hodson, et al.
Clinical Chemistry and Laboratory Medicine
|
July 4, 2023
Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease
Marith van Schrojenstein Lantman, Anne-Els van de Logt, Elma Prudon-Rosmulder, et al.
Kidney International
|
September 5, 2020
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients
Lena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
Orphanet Journal of Rare Diseases
|
June 3, 2021
The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results
Giulia Bassanese, Tanja Wlodkowski, Aude Servais, et al.
Kidney International
|
November 9, 2020
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernández-Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, et al.
Kidney International
|
December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
Fadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Autoimmunity Reviews
|
September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Page
of 4